Triple

T391443
Position Surface form Disambiguated ID Type / Status
Subject Johnson & Johnson E8888 entity
Predicate covid19VaccineBrand P1500 FINISHED
Object Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
E49854 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Janssen COVID-19 Vaccine | Statement: [Johnson & Johnson, covid19VaccineBrand, Janssen COVID-19 Vaccine]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Janssen COVID-19 Vaccine
Context triple: [Johnson & Johnson, covid19VaccineBrand, Janssen COVID-19 Vaccine]
  • A. Leqembi
    Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
  • B. Vaccine Education Center
    The Vaccine Education Center is a program at the Children's Hospital of Philadelphia that provides evidence-based information to the public about vaccines, vaccine safety, and immunization practices.
  • C. Vumerity
    Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
  • D. Aduhelm
    Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
  • E. Roche
    Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Janssen COVID-19 Vaccine
Triple: [Johnson & Johnson, covid19VaccineBrand, Janssen COVID-19 Vaccine]
Generated description
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Janssen COVID-19 Vaccine
Target entity description: The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
  • A. Leqembi
    Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
  • B. Vaccine Education Center
    The Vaccine Education Center is a program at the Children's Hospital of Philadelphia that provides evidence-based information to the public about vaccines, vaccine safety, and immunization practices.
  • C. Vumerity
    Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
  • D. Aduhelm
    Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
  • E. Roche
    Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: covid19VaccineBrand
Context triple: [Johnson & Johnson, covid19VaccineBrand, Janssen COVID-19 Vaccine]
  • A. parentBrand
    Indicates that one brand is the overarching or owning brand from which another brand is derived or subordinated.
  • B. manufacturedBy
    Indicates that an item or product is produced or created by a specific manufacturer or maker.
  • C. formulatedIn
    Indicates that something was created, developed, or expressed within a particular context, place, or framework.
  • D. formerBrand
    Indicates that an entity was previously used or recognized as a brand for another entity but is no longer its current brand.
  • E. brand chosen
    Indicates that one entity is the commercial brand or label under which another entity (such as a product, service, or organization) is marketed or identified.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a2e7f55c60819097aff65ea2ca2832 completed Feb. 28, 2026, 1:04 p.m.
NER Named-entity recognition batch_69a2ec5d73e881909101308a583c8f13 completed Feb. 28, 2026, 1:23 p.m.
NED1 Entity disambiguation (via context triple) batch_69a405f74cd08190a2e165506638607c completed March 1, 2026, 9:25 a.m.
NEDg Description generation batch_69a406a17fdc8190a067217b806fbc57 completed March 1, 2026, 9:28 a.m.
NED2 Entity disambiguation (via description) batch_69a4070050dc81909fdfbcfce23e428e completed March 1, 2026, 9:29 a.m.
PD Predicate disambiguation batch_69a2e96a8ca48190abbd8de9b02c115c completed Feb. 28, 2026, 1:11 p.m.
Created at: Feb. 28, 2026, 1:08 p.m.